Lv5
1261 积分 2021-04-12 加入
Pathologic Assessment After Neoadjuvant Chemotherapy for NSCLC: Importance and Implications of Distinguishing Adenocarcinoma From Squamous Cell Carcinoma
21天前
已完结
Pathological response after neoadjuvant chemotherapy in resectable non-small-cell lung cancers: proposal for the use of major pathological response as a surrogate endpoint
21天前
已完结
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
21天前
已完结
Adjuvant Immunotherapy Should Be Used in Patients With Non-Small Cell Carcinoma With a Pathologic Complete Response to Neoadjuvant Immunotherapy
1个月前
已完结
Adjuvant Immunotherapy Should Not be Used in Patients With a Pathologic Complete Response to Neoadjuvant Chemoimmunotherapy
1个月前
已完结
Pathologic response and nodal status guide adjuvant immunotherapy in non–small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study
1个月前
已完结
多臂机器人辅助单孔肺切除术中国临床专家共识
1个月前
已完结
A Self-Supervised Foundation Model Based on Three-Dimensional Chest CT Scans for Lung Cancer Diagnosis and Prognosis Prediction
1个月前
已完结
Integrating Histologic Descriptors into the Ninth Edition TNM Staging Improves Prognostic Stratification of Lung Adenocarcinoma
2个月前
已完结
Pathologic response and nodal status guide adjuvant immunotherapy in non–small cell lung cancer after neoadjuvant chemoimmunotherapy: An eastern Asian cohort study
4个月前
已完结
皖公网安备34019202002308
